The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Platinum Complexes as Anticancer Agents
Abstract
The application of inorganic chemistry to medicine is a rapidly developing field, and novel therapeutic and diagnostic metal complexes are now having an impact on medical practice. Advances in biocoordination chemistry are crucial for improving the design of compounds to reduce toxic side effects and understand their mechanisms of action. Cisplatin, as one of the leading metal-based drugs, is widely used in the treatment of cancer. Significant side effects and drug resistance, however, have limited its clinical applications. Biological carriers conjugated to cisplatin analogs have improved specificity for tumor tissue, thereby reducing side effects and drug resistance. Platinum complexes with distinctively different DNA binding modes from that of cisplatin also exhibit promising pharmacological properties. This review focuses on recent advances in developing platinum anticancer agents with an emphasis on platinum coordination complexes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,949
Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927
Metal Complexes as Photo- and Radiosensitizers
Ali, H., & van Lier, J. E. (1999) · Chemical Reviews · doi:10.1021/cr980439y · Cited by 848
Platinum(IV) antitumour compounds: their bioinorganic chemistry
Hall, M. D., & Hambley, T. W. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00026-7 · Cited by 622
Cisplatin: From DNA damage to cancer chemotherapy
Cohen, S. M., & Lippard, S. J. (2001) · Progress in Nucleic Acid Research and Molecular Biology · doi:10.1016/s0079-6603(01)67026-0 · Cited by 615
Antidiabetic vanadium(IV) and zinc(II) complexes
Sakurai, H., Kojima, Y., Yoshikawa, Y., Kawabe, K., & Yasui, H. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(01)00447-7 · Cited by 537
Medicinal Inorganic Chemistry: Introduction
Orvig, C., & Abrams, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980419w · Cited by 532
Tumour-inhibiting platinum complexes—state of the art and future perspectives
Jakupec, M. A., Galanski, M. S., & Keppler, B. K. (2003) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/s10254-002-0001-x · Cited by 434
New Cisplatin Analogues in Development: A Review
Weiss, R. B., & Christian, M. C. (1993) · Drugs · doi:10.2165/00003495-199346030-00003 · Cited by 404
Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy
(1991) · Springer eBooks · doi:10.1007/978-1-4899-0738-7 · Cited by 374
Recognition of cisplatin adducts by cellular proteins
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 349
Metal Complexes as Enzyme Inhibitors
Louie, A. Y., & Meade, T. J. (1999) · Chemical Reviews · doi:10.1021/cr9804285 · Cited by 301
Coordination chemistry of metals in medicine: target sites for bismuth
Sadler, P. J., Li, H., & Sun, H. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(99)00018-1 · Cited by 280
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 209
The mismatch-repair protein hMSH2 binds selectively to DNA adducts of the anticancer drug cisplatin
Mello, J. A., Acharya, S., Fishel, R., & Essigmann, J. M. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90149-0 · Cited by 199
Nishiyama, N., Kato, Y., Sugiyama, Y., & Kataoka, K. (2001) · Pharmaceutical Research · doi:10.1023/a:1010908916184 · Cited by 186
Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro
Lee, K.-B., Wang, D., Lippard, S. J., & Sharp, P. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072068399 · Cited by 181
p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells
Zamble, D. B., Jacks, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6163 · Cited by 169
Molecular aspects of resistance to antitumor platinum drugs
Brabec, V., & Kasparkova, J. (2002) · Drug Resistance Updates · doi:10.1016/s1368-7646(02)00047-x · Cited by 161
DNA Interstrand Cross-links of the Novel Antitumor Trinuclear Platinum Complex BBR3464
Kašpárková, J., Zehnulová, J., Farrell, N. P., & Brabec, V. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208016200 · Cited by 147
A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kèlland, L. R., BARNARD, C. F. J., Mellish, K. J., Jones, M. A., Goddard, P. M., Valenti, M. R., Bryant, A., Murrer, B. A., & Harrap, K. R. (1994) · PubMed · Cited by 140
Pratesi, G., Perego, P., Polizzi, D., Righetti, S. C., Supino, R., Caserini, C., Manzotti, C., Giuliani, F. C., Pezzoni, G., Tognella, S., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690620 · Cited by 135
Current status of the development of trans-platinum antitumor drugs
Perez, J. M. T., Fuertes, M. A., Alonso‐Moreno, C., & Navarro‐Ranninger, C. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00053-6 · Cited by 125
Farrell, N. P. (1993) · Cancer Investigation · doi:10.3109/07357909309011676 · Cited by 121
Soluble Tetraarylporphyrin−Platinum Conjugates as Cytotoxic and Phototoxic Antitumor Agents
Lottner, C., Bart, K.-C., Bernhardt, G., & Brunner, H. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0110690 · Cited by 108
Baruah, H., Barry, C. G., & Bierbach, U. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387313 · Cited by 108
Nucleotide Excision Repair from Site-Specifically Platinum-Modified Nucleosomes
Wang, D., Hara, R., Singh, G., Sancar, A., & Lippard, S. J. (2003) · Biochemistry · doi:10.1021/bi034264k · Cited by 107
Nováková, O., Kasparkova, J., Malina, J., Natile, G., & Brabec, V. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg863 · Cited by 105
Jackson, A. R., Davis, J., Pither, R. J., Rodger, A., & Hannon, M. J. (2001) · Inorganic Chemistry · doi:10.1021/ic010152a · Cited by 94
Testis-specific HMG-domain protein alters the responses of cells to cisplatin
Zamble, D. B., Mikata, Y., Eng, C. H., Sandman, K. E., & Lippard, S. J. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00472-5 · Cited by 83
Zehnulová, J., Kašpárková, J., Farrell, N. P., & Brabec, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103118200 · Cited by 81
Monti, E., Gariboldi, M. B., Maiocchi, A., Marengo, E., Cassino, C., Gabano, E., & Osella, D. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049508t · Cited by 78
Khazanov, E., Barenholz, Y., Gibson, D., & Najajreh, Y. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020817y · Cited by 65
Cytotoxic Activity of Metal Complexes of Biogenic Polyamines: Polynuclear Platinum(II) Chelates
Teixeira, L. J., Seabra, M., Reis, E., da Cruz, M. T. G., de Lima, M. C. P., Pereira, E., Miranda, M. A., & Marques, M. P. M. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0311238 · Cited by 61
Farrell, N. P., Povirk, L. F., Dange, Y., DeMasters, G. A., Gupta, M. S., Kohlhagen, G., Khan, Q. A., Pommier, Y. G., & Gewirtz, D. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.023 · Cited by 57
Marques, M. P. M., Girão, T., de Lima, M. C. P., Gameiro, A. M., Pereira, E., & Garcia, P. M. L. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00186-0 · Cited by 51
Ohya, Y., Oue, H., Nagatomi, K., & Ouchi, T. (2001) · Biomacromolecules · doi:10.1021/bm010053o · Cited by 50
Hall, M. D., Martin, C., Ferguson, D. J. P., Phillips, R. M., Hambley, T. W., & Callaghan, R. (2003) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.07.016 · Cited by 49
Gatti, L., Supino, R., Perego, P., Pavesi, R., Caserini, C., Carenini, N., Righetti, S. C., Zuco, V., & Zunino, F. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401109 · Cited by 45
Pérez, J. M., Montero, E. I., González, A. M., Álvarez-Valdés, A., Alonso, C., & Navarro‐Ranninger, C. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00143-9 · Cited by 42
Nguewa, P., Fuertes, M. A., Iborra, S., Najajreh, Y., Gibson, D., Martinez, E. C., Alonso‐Moreno, C., & Perez, J. M. T. (2005) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.12.008 · Cited by 39
Moradell, S., Lorenzo, J., Rovira, A. M., et al. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.08.011 · Cited by 37
Kašpárková, J., Pospíšilová, Š., & Brabec, V. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101224200 · Cited by 35
Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzymea
Colangelo, D., Ghiglia, A. L., Viano, I., Cavigiolio, G., & Osella, D. (2003) · BioMetals · doi:10.1023/a:1023428315746 · Cited by 23
Neuse, E. W., Mphephu, N., Netshifhefhe, H. M., & Johnson, M. T. (2002) · Polymers for Advanced Technologies · doi:10.1002/pat.241 · Cited by 16
Structure-antitumour activity relationships for new platinum complexes
Craciunescu, D. G., Doadrio, A. L., Furlani, A., & Scarcia, V. (1982) · Chemico-Biological Interactions · doi:10.1016/0009-2797(82)90129-6 · Cited by 14
Kodaka, M., Dohta, Y., Rekonen, P., Okada, T., & Okuno, H. (1998) · Biophysical Chemistry · doi:10.1016/s0301-4622(98)00213-0 · Cited by 11
Cis- and trans-platinum and palladium complexes: a comparative study review as antitumour agents.
Al‐Allaf, T. A. K., & Rashan, L. J. (2001) · PubMed · Cited by 10
Cited by
Targeting and delivery of platinum-based anticancer drugs
Wang, X., & Guo, Z. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35259a · Cited by 684
Ray, S., Mohan, R., Singh, J. K., Samantaray, M. K., Shaikh, M. M., Panda, D., & Ghosh, P. (2007) · Journal of the American Chemical Society · doi:10.1021/ja075889z · Cited by 656
Novel Metals and Metal Complexes as Platforms for Cancer Therapy
Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210791209009 · Cited by 552
Jeyaraj, M., Gurunathan, S., Qasim, M., Kang, M.-H., & Kim, J.-H. (2019) · Nanomaterials · doi:10.3390/nano9121719 · Cited by 481
Knoll, J. D., & Turro, C. (2015) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2014.05.018 · Cited by 423
Metadata
- Authors
- Kostova, I.
- Venue
- Recent Patents on Anti-Cancer Drug Discovery
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2006-01-01
- Volume
- 1
- Issue
- 1
- Pages
- 1-22
- ISSN
- 1574-8928 (ISSN-L)
- OpenAlex
- W2097607581
- Cited by
- 493
- References
- 49
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.